Galenus Precision Pharmacy Celebrates Mt. Laurel Grand Opening

On Apr 1, 2026

Galenus Precision Pharmacy, Inc., doing business ass GalenusCare, celebrated the grand opening of its location in Mount Laurel, expanding access to advanced medication management for Programs of All-Inclusive Care for the Elderly (PACE) and hospice providers across the United States.

Funding for the center, which serves as the company’s national headquarters, was supported in part by the New Jersey Economic Development Authority (NJEDA).

GalenusCare improves outcomes for individuals with complex, chronic conditions through personalized, pharmacist-led care supported by advanced clinical science and technology. In the United States, 42% of adults 65 and older take five or more prescription medications—a condition known as polypharmacy—which significantly increases the risk of preventable and predictable adverse drug events such as falls, emergency department visits, hospitalizations, and premature death. Each day, an estimated 750 older adults are hospitalized and more than 400 die due to medication-related complications. GalenusCare helps care teams proactively identify, manage, and prevent this risk through advanced analytics and precision pharmacy services.

“This opening marks an important step forward in our mission to redefine medication management for medically complex populations” said Dr. Calvin Knowlton, CEO and co-founder of GalenusCare. “Our purpose is to shift the paradigm from preference-based trial and error medication regimens to using science and advanced pharmacist practitioners to optimize medication combinations that are both personalized and precise.  Precision pharmacy should be a foundational part of care delivery—enabling earlier intervention, reducing avoidable harm, and improving outcomes at scale. We’re grateful to our partners and community members for their ongoing belief in our vision and the meaningful impact we can achieve together.”

“With NJEDA’s support, GalenusCare is advancing accessible, high‑quality care for New Jersey residents while expanding its reach nationwide,” said NJEDA Chief Economic Transformation Officer Kathleen Coviello. “We are proud that Dr. Knowlton continues to choose New Jersey as the place to build and grow his companies. Founders like him are essential to strengthening our innovation economy, creating good‑paying jobs, and reinforcing New Jersey’s leadership in health care and technology.”

“Medication management should strengthen care—not complicate it,” said GalenusCare President & Co-Founder Dr. Orsula Knowlton, “Our model integrates pharmacist collaboration and clinical insights directly into care team workflows, helping teams deliver safer, higher-quality care with greater efficiency.”

To access more business news, visit NJB News Now.

Related Articles: